Vanda Pharmaceuticals Inc.
VNDA
$8.81
-$0.48-5.17%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -141.19M | -22.59M | -27.21M | -29.49M | -4.91M |
| Total Depreciation and Amortization | 5.86M | 2.05M | 2.02M | 1.98M | 3.64M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 102.88M | -2.97M | -5.39M | -3.72M | -1.26M |
| Change in Net Operating Assets | 3.03M | -8.13M | 15.32M | -1.91M | 718.00K |
| Cash from Operations | -29.42M | -31.63M | -15.25M | -33.15M | -1.82M |
| Capital Expenditure | -102.00K | -161.00K | -299.00K | -436.00K | -214.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 44.97M | 21.52M | -14.97M | 44.34M | 4.21M |
| Cash from Investing | 44.87M | 21.36M | -15.27M | 43.90M | 3.99M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -640.00K | -517.00K | -425.00K | -409.00K | -155.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | -915.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -640.00K | -517.00K | -425.00K | -1.32M | -155.00K |
| Foreign Exchange rate Adjustments | 20.00K | -180.00K | 134.00K | 49.00K | -202.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.83M | -10.96M | -30.81M | 9.48M | 1.82M |